Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Operating Expenses (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Operating Expenses for 11 consecutive years, with $7.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses rose 3.53% to $7.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $28.4 million, a 4.46% increase, with the full-year FY2024 number at $27.8 million, up 2.96% from a year prior.
  • Operating Expenses was $7.1 million for Q3 2025 at KORU Medical Systems, up from $6.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $7.3 million in Q1 2025 to a low of $4.6 million in Q2 2021.
  • A 5-year average of $6.5 million and a median of $6.7 million in 2022 define the central range for Operating Expenses.
  • Biggest YoY gain for Operating Expenses was 71.73% in 2021; the steepest drop was 22.73% in 2021.
  • KORU Medical Systems' Operating Expenses stood at $5.9 million in 2021, then grew by 10.84% to $6.6 million in 2022, then fell by 0.93% to $6.5 million in 2023, then grew by 9.56% to $7.2 million in 2024, then decreased by 0.28% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Operating Expenses are $7.1 million (Q3 2025), $6.8 million (Q2 2025), and $7.3 million (Q1 2025).